StonvexLoading…
StonvexStonvexStonvexCore line items from CROX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $921.46M | $4.04B | $3.08B | $2.09B |
Operating Income | $200.84M | $149.51M | $3.12M | $-204.54M |
Net Income | $137.56M | $-81.20M | $-186.36M | $-332.18M |
EPS (Diluted) | $2.71 | $-1.50 | $-3.38 | $-5.94 |
Total Assets | $4.34B | $4.17B | $4.30B | $4.45B |
Total Liabilities | $2.92B | $2.88B | $2.94B | $3.03B |
Cash & Equivalents | $130.88M | $130.35M | $153.97M | $200.61M |
Free Cash Flow OCF − CapEx | $-98.93M | $659.20M | $412.78M | $186.62M |
Shares Outstanding | 50.40M | 50.20M | 52.40M | 54.80M |